1. Home
  2. KEQU vs MAIA Comparison

KEQU vs MAIA Comparison

Compare KEQU & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$34.92

Market Cap

106.6M

Sector

Industrials

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.48

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
MAIA
Founded
1906
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
89.7M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
KEQU
MAIA
Price
$34.92
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.2K
1.1M
Earning Date
03-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.53
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.44
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$0.87
52 Week High
$60.89
$3.19

Technical Indicators

Market Signals
Indicator
KEQU
MAIA
Relative Strength Index (RSI) 29.36 37.60
Support Level N/A $1.44
Resistance Level $41.38 $1.52
Average True Range (ATR) 1.29 0.09
MACD -0.81 -0.01
Stochastic Oscillator 0.00 49.56

Price Performance

Historical Comparison
KEQU
MAIA

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: